Recombinant human activated protein C: current insights into its mechanism of action
Authors:
Open Access
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 11 (Suppl 5) , S3
Abstract
Impairment of the protein C pathway plays a central role in the pathogenesis of sepsis. Administration of recombinant human activated protein C (rhAPC) may correct the dysregulated anticoagulant mechanism and prevent propagation of thrombin generation and formation of microvascular thrombosis. Furthermore, it may simultaneously modulate the inflammatory response. It is likely that the beneficial effect of rhAPC observed in experimental and clinical studies of severe sepsis results from a combination of mechanisms that modulate the entangled processes of coagulation and inflammation. This review presents an analysis of the various mechanisms of action of rhAPC in sepsis.Keywords
This publication has 61 references indexed in Scilit:
- Novel Role of the Human Alveolar Epithelium in Regulating Intra-Alveolar CoagulationAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primatesBlood, 2007
- The safety profile of drotrecogin alfa (activated)Critical Care, 2007
- Clinical trials in severe sepsis with drotrecogin alfa (activated)Critical Care, 2007
- The protein C pathway: implications for the design of the RESPOND studyCritical Care, 2007
- Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiencyBlood, 2006
- Endotoxaemia induces resistance to activated protein C in healthy humansBritish Journal of Haematology, 2006
- Expression and function of the endothelial protein C receptor in human neutrophilsBlood, 2003
- Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotectiveNature Medicine, 2003
- New Mechanisms for Vascular Control of Inflammation Mediated by Natural Anticoagulant ProteinsJournal of Experimental Medicine, 2002